Editorial: Lithium inhibition of cAMP-mediated hormones: a caution.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002254:Carbonates; D000242:Cyclic AMP / Q000502:physiology*; D003919:Diabetes Insipidus / Q000139:chemically induced; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007010:Hyponatremia / Q000188:drug therapy; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D009994:Osmolar Concentration; D051381:Rats; D012964:Sodium / Q000097:blood; D013577:Syndrome; D013972:Thyrotropin / Q000037:antagonists & inhibitors*; D014667:Vasopressins / Q000037:antagonists & inhibitors* / Q000378:metabolism
D002254:Carbonates; D014667:Vasopressins; D013972:Thyrotropin; D008094:Lithium; D012964:Sodium; D000242:Cyclic AMP; D000262:Adenylyl Cyclases